Old API Wind-down Ltd - Ordinary Shares ARLZQ

RE:RE:RE:More news out today

[kuatolives]

I'm sure we'll see some kind of a pop once the drug is approved then followed by lots of selling into the strength as people get back to even or take some profits. And that's fine. The real growth in the sp will likely happen once we start getting a couple of quarters of Yosprala on the books and revenues start to substantially grow. We'll have one more quarter here with a high cash burn as the drug reps are sent out into the world with no real revenue to offset their costs, but that's what the Deefield cash as for. We are well positioned though as the drug costs us nothing in licensing fees and wasn't acquired through debt, which the market really dislikes right now given the adventures of Valeant. Just gotta wait and be patient.